MRNA logo

Moderna (MRNA)

Profile

Full Name

Moderna, Inc.

Ticker Symbol

MRNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 7, 2018

Indexes

S&P 500

Website

http://www.modernatx.com

Employees

5800

Key Details

Price

$30.49(+0.69%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.20B(-52.64% YoY)

Annual EPS

-$9.28(+24.74% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $30.49
    MRNA price is $30.49

    30-Day Relative Volume

    0.65
    MRNA 30-day relative volume is 0.65

    Price Performance

    Price Today change

    +0.69%
    MRNA price is up +0.69% today

    Price YTD change

    -26.67%
    MRNA price is down -26.67% since January 1st

    Price 1-year change

    -73.7%
    MRNA price is down -73.7% year-on-year

    Price 3-year change

    -79.67%
    MRNA price is down -79.67% over the past 3 years

    Price Range

    Price All-time high

    $497.49
    MRNA price is currently -93.87% below its historical high of $497.49

    Price 3-year low

    $23.15
    MRNA price is currently +31.71% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $11.79B
    MRNA market capitalization is $11.79 billion

    Market cap 3-year change

    -79.94%
    MRNA market capitalization is down -79.94% over the past 3 years

    Market cap All-time high

    $195.55B
    MRNA market capitalization is currently -93.97% below its historical high of $195.55 billion

    Market cap sector rank

    93.13%
    MRNA market capitalization is higher than 93.13% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.71%
    MRNA shares outstanding is up +0.71% year-on-year

    Shares Outstanding 3-Year Change

    -1.34%
    MRNA shares outstanding is down -1.34% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.25
    MRNA beta is 1.25

    200-day SMA

    $38.22
    MRNA price is currently -20.22% below its 200-day simple moving average

    50-day SMA

    $26.70
    MRNA price is currently +14.20% above its 50-day simple moving average

    RSI

    67.78
    MRNA 14-day relative strength index is 67.78

    Volume

    0.65
    MRNA 30-day relative volume is 0.65

    ATR

    $1.33
    MRNA average true range is $1.33

    10-day Historical Volatility

    36.35%
    MRNA 10-day historical volatility is 36.35%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.20B
    MRNA annual revenue is $3.20 billion

    Revenue Analysts estimate

    $2.07B
    MRNA annual revenue is currently +54.45% higher than the consensus analysts' forecast

    Revenue 1-year change

    -52.64%
    MRNA annual revenue is down -52.64% year-on-year

    Revenue Sector rank

    89.38%
    MRNA annual revenue is higher than 89.38% of companies in Healthcare sector

    EPS

    EPS

    -$9.28
    MRNA annual earnings per share is -$9.28

    EPS Analysts estimate

    -$10.10
    MRNA annual earnings per share is currently -8.16% lower than the consensus analysts' forecast

    EPS 1-year change

    +24.74%
    MRNA annual earnings per share is up +24.74% year-on-year

    EPS Sector rank

    13.51%
    MRNA annual earnings per share is higher than 13.51% of companies in Healthcare sector

    Profit

    Gross profit

    $1.77B
    MRNA annual gross profit is $1.77 billion

    Gross margin

    54.76%
    MRNA annual gross profit margin is 54.76%

    Operating profit

    -$3.94B
    MRNA annual operating income is -$3.94 billion

    Operating margin

    -121.91%
    MRNA annual operating profit margin is -121.91%

    Net income

    -$3.56B
    MRNA annual net profit is -$3.56 billion

    Net margin

    -110.04%
    MRNA annual net profit margin is -110.04%

    Expenses

    Total expenses

    $7.18B
    MRNA annual total expenses is $7.18 billion

    Operating expenses

    $5.72B
    MRNA annual total operating expenses is $5.72 billion

    Cost of goods sold

    $1.46B
    MRNA annual cost of goods sold is $1.46 billion

    Selling, general & administrative expenses

    $1.17B
    MRNA annual SGA is $1.17 billion

    Depreciation and amortization

    $189.00M
    MRNA annual depreciation & amortization is $189.00 million

    Interest expense

    $24.00M
    MRNA annual interest expense is $24.00 million

    Income tax

    -$46.00M
    MRNA annual income tax is -$46.00 million

    EBIT & EBITDA

    EBIT

    -$3.94B
    MRNA annual earnings before interest & taxes is -$3.94 billion

    EBITDA

    -$3.76B
    MRNA annual EBITDA is -$3.76 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $14.14B
    MRNA annual total assets is $14.14 billion

    Non current assets

    $6.04B
    MRNA annual long term assets is $6.04 billion

    Current assets

    $8.10B
    MRNA annual total current assets is $8.10 billion

    Cash and cash equivalents

    $1.93B
    MRNA annual cash & cash equivalents is $1.93 billion

    Accounts receivable

    $358.00M
    MRNA annual accounts receivable is $358.00 million

    Inventory

    $117.00M
    MRNA annual inventory is $117.00 million

    Liabilities

    Total liabilities

    $3.24B
    MRNA annual total liabilities is $3.24 billion

    Long term liabilities

    $1.03B
    MRNA annual total long term liabilities is $1.03 billion

    Current liabilities

    $2.21B
    MRNA annual total current liabilities is $2.21 billion

    Accounts payable

    $405.00M
    MRNA annual accounts payable is $405.00 million

    Debt

    Total debt

    $747.00M
    MRNA annual total debt is $747.00 million

    Total debt 1-year change

    -39.9%
    MRNA annual total debt is down -39.9% year-on-year

    Long term debt

    $710.00M
    MRNA annual long term debt is $710.00 million

    Short term debt

    $37.00M
    MRNA annual short term debt is $37.00 million

    Equity & Capital

    Shareholders equity

    $10.90B
    MRNA annual stockholders equity is $10.90 billion

    Book value

    $10.90B
    MRNA annual book value is $10.90 billion

    Retained earnings

    $10.04B
    MRNA annual retained earnings is $10.04 billion

    Working capital

    $5.89B
    MRNA annual working capital is $5.89 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$3.00B
    MRNA annual cash flow from operations is -$3.00 billion

    Cash from operations 1-year change

    +3.66%
    MRNA annual cash flow from operations is up +3.66% year-on-year

    Cash from investing

    $1.95B
    MRNA annual cash flow from investing activities is $1.95 billion

    Cash from investing 1-year change

    -53.66%
    MRNA annual cash flow from investing activities is down -53.66% year-on-year

    Cash from financing

    $56.00M
    MRNA annual cash flow from financing activities is $56.00 million

    Cash from financing 1-year change

    +104.07%
    MRNA annual cash flow from financing activities is up +104.07% year-on-year

    CAPEX

    CAPEX

    $1.05B
    MRNA annual capital expenditures is $1.05 billion

    CAPEX 1-year change

    +48.66%
    MRNA annual capital expenditures is up +48.66% year-on-year

    Free Cash Flow

    Free cash flow

    -$4.05B
    MRNA annual free cash flow is -$4.05 billion

    Free cash flow 1-year change

    -6.01%
    MRNA annual free cash flow is down -6.01% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    54.76%
    MRNA annual gross profit margin is 54.76%

    Operating margin

    -121.91%
    MRNA annual operating profit margin is -121.91%

    Net margin

    -110.04%
    MRNA annual net profit margin is -110.04%

    ROA & ROE

    ROA

    -21.87%
    MRNA annual return on assets is -21.87%

    ROE

    -28.77%
    MRNA annual return on equity is -28.77%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MRNA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MRNA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.17
    MRNA price to book ratio is 1.17

    PB ratio Sector rank

    43.41%
    MRNA price to book ratio is higher than 43.41% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.76
    MRNA price to sales ratio is 3.76

    PS ratio Sector rank

    56.75%
    MRNA price to sales ratio is higher than 56.75% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $10.91B
    MRNA enterprise value is $10.91 billion

    Enterprise value Sector rank

    91.91%
    MRNA enterprise value is higher than 91.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.42
    MRNA EV/EBITDA is -3.42

    EV/EBITDA Sector rank

    29.18%
    MRNA EV/EBITDA is higher than 29.18% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.67
    MRNA annual current ratio is 3.67

    Quick ratio

    3.62
    MRNA annual quick ratio is 3.62

    Leverage

    Debt to equity

    0.00
    MRNA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -164.38
    MRNA annual interest coverage ratio is -164.38

    Risk & Stability

    Piotroski F-Score

    3
    MRNA piotroski f-score is 3

    Altman Z-Score

    2.98
    MRNA altman z-score is 2.98

    Analyst ratings

    Recent major analysts updates

    May 22, 25 JP Morgan
    Underweight
    May 2, 25 UBS
    Buy
    May 2, 25 RBC Capital
    Sector Perform
    May 2, 25 Evercore ISI Group
    In-Line
    May 2, 25 Barclays
    Equal-Weight
    Apr 9, 25 Morgan Stanley
    Equal-Weight
    Mar 21, 25 JP Morgan
    Underweight
    Mar 13, 25 Citigroup
    Neutral
    Feb 19, 25 UBS
    Buy
    Feb 18, 25 RBC Capital
    Sector Perform

    Institutional Ownership

    Screeners with MRNA included

    Growing Shares Outstanding
    US stocks
    S&P 500 companies earnings calendar
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    • What is the ticker symbol for Moderna?
    • Does Moderna pay dividends?
    • What sector is Moderna in?
    • What industry is Moderna in?
    • What country is Moderna based in?
    • When did Moderna go public?
    • Is Moderna in the S&P 500?
    • Is Moderna in the NASDAQ 100?
    • Is Moderna in the Dow Jones?
    • When was Moderna's last earnings report?
    • When does Moderna report earnings?
    • Should I buy Moderna stock now?

    What is the ticker symbol for Moderna?

    The ticker symbol for Moderna is NASDAQ:MRNA

    Does Moderna pay dividends?

    No, Moderna does not pay dividends

    What sector is Moderna in?

    Moderna is in the Healthcare sector

    What industry is Moderna in?

    Moderna is in the Biotechnology industry

    What country is Moderna based in?

    Moderna is headquartered in United States

    When did Moderna go public?

    Moderna's initial public offering (IPO) was on December 7, 2018

    Is Moderna in the S&P 500?

    Yes, Moderna is included in the S&P 500 index

    Is Moderna in the NASDAQ 100?

    No, Moderna is not included in the NASDAQ 100 index

    Is Moderna in the Dow Jones?

    No, Moderna is not included in the Dow Jones index

    When was Moderna's last earnings report?

    Moderna's most recent earnings report was on May 1, 2025

    When does Moderna report earnings?

    The next expected earnings date for Moderna is Aug 1, 2025

    Should I buy Moderna stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page